Our top pick for
Beginners
Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our opinions or reviews. Learn how we make money.
How to buy Cyclo Therapeutics stock | 0.12
Own Cyclo Therapeutics stock in just a few minutes.
Cyclo Therapeutics stock is currently available to purchase as an over-the-counter (OTC) stock on the OTCQB. But many popular brokerages don't offer access to OTC stocks.
Cyclo has recently filed with the SEC to list stock on the Nasdaq Capital Market. This will make it possible to buy its stock from any major stock broker.
How to buy shares in Cyclo Therapeutics
- Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
- Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
- Search for Cyclo Therapeutics. Find the stock by name or ticker symbol: CTDH. Research its history to confirm it's a solid investment against your financial goals.
- Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Cyclo Therapeutics reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
- Decide on how many to buy. At last close price of USD$0.12, weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of Cyclo Therapeutics, depending on your broker.
- Check in on your investment. Congratulations, you own a part of Cyclo Therapeutics. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.
How has coronavirus impacted Cyclo Therapeutics's share price?
Since the stock market crash in March caused by coronavirus, Cyclo Therapeutics's share price has had significant negative movement.
Its last market close was USD$0.12, which is 40.00% down on its pre-crash value of USD$0.2 and 50.00% up on the lowest point reached during the March crash when the shares fell as low as USD$0.08.
If you had bought USD$1,000 worth of Cyclo Therapeutics shares at the start of February 2020, those shares would have been worth USD$818.18 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth USD$545.45.
Cyclo Therapeutics share price
Use our graph to track the performance of CTDH stocks over time.Cyclo Therapeutics shares at a glance
Information last updated 2020-10-16.
| Latest market close | USD$0.12 |
|---|---|
| 52-week range | USD$0.08 - USD$0.3499 |
| 50-day moving average | USD$0.1444 |
| 200-day moving average | USD$0.1555 |
| Wall St. target price | USD$1.25 |
| PE ratio | N/A |
| Dividend yield | N/A (0%) |
| Earnings per share (TTM) | USD$-0.059 |
Compare trading platforms
Compare special offers, low fees and a wide range of types of investments among top trading platforms.The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Cyclo Therapeutics stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Cyclo Therapeutics price performance over time
Historical closes compared with the close of $0.12 from 2020-10-19
| 1 week (2020-10-16) | 0.12 |
|---|---|
| 1 month (2020-09-25) | -7.69% |
| 3 months (2020-07-24) | -14.29% |
| 6 months (2020-04-24) | -29.41% |
| 1 year (2019-10-25) | -36.84% |
|---|---|
| 2 years (2018-10-24) | -78.38% |
| 3 years (2017-10-24) | -70.00% |
| 5 years (2015-10-23) | -79.66% |
Cyclo Therapeutics financials
| Revenue TTM | USD$1 million |
|---|---|
| Gross profit TTM | USD$769,638 |
| Return on assets TTM | -115.58% |
| Return on equity TTM | -622.39% |
| Profit margin | 0% |
| Book value | $0.029 |
| Market capitalisation | USD$19.7 million |
TTM: trailing 12 months
Cyclo Therapeutics share dividends
We're not expecting Cyclo Therapeutics to pay a dividend over the next 12 months.
Have Cyclo Therapeutics's shares ever split?
Cyclo Therapeutics's shares were split on a 2:1 basis on 22 May 2000. So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your Cyclo Therapeutics shares – just the quantity. However, indirectly, the new 50% lower share price could have impacted the market appetite for Cyclo Therapeutics shares which in turn could have impacted Cyclo Therapeutics's share price.
Cyclo Therapeutics share price volatility
Over the last 12 months, Cyclo Therapeutics's shares have ranged in value from as little as $0.08 up to $0.3499. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (OTCQB average) beta is 1, while Cyclo Therapeutics's is -0.4986. This would suggest that Cyclo Therapeutics's shares have been inversely-correlated to the average (for this exchange) – so when the broader market trended up or down, Cyclo Therapeutics has bucked the trend.
To put Cyclo Therapeutics's beta into context you can compare it against those of similar companies.
- Inovio Pharmaceuticals (INO.US): 1.021
- Regeneron Pharmaceuticals (REGN.US): 0.5014
- Novavax (NVAX.US): 1.3855
Cyclo Therapeutics overview
Cyclo Therapeutics, Inc., a biotechnology company, develops cyclodextrin-based products for the treatment of diseases. Its lead drug candidate is Trappsol Cyclo, an orphan drug for the treatment of Niemann-Pick Type C disease. The company also sells cyclodextrins and related products to the pharmaceutical, nutritional, and other industries, primarily for use in diagnostics and specialty drugs. It has a collaboration with the Chattanooga Center for Neurologic Research. The company was formerly known as CTD Holdings, Inc. and changed its name to Cyclo Therapeutics, Inc. in October 2019. Cyclo Therapeutics, Inc. was founded in 1990 and is based in Gainesville, Florida.
Frequently asked questions
More guides on Finder
-
How to buy Workiva stock | 56.61
Steps to owning and managing WK, with 24-hour and historical pricing before you buy.
-
How to buy Welltower stock
Steps to owning and managing HCN, with 24-hour and historical pricing before you buy.
-
How to buy Velocity Financial stock | 4.49
Steps to owning and managing VEL, with 24-hour and historical pricing before you buy.
-
How to buy Lear Corporation stock | 134.51
Steps to owning and managing LEA, with 24-hour and historical pricing before you buy.
-
How to buy Lubys stock | 2.74
Steps to owning and managing LUB, with 24-hour and historical pricing before you buy.
-
How to buy Healthcare Services Group stock | 23.6
Steps to owning and managing HCSG, with 24-hour and historical pricing before you buy.
-
How to buy Lawson Products stock | 46.56
Steps to owning and managing LAWS, with 24-hour and historical pricing before you buy.
-
How to buy Sierra Wireless stock | 11.47
Steps to owning and managing SWIR, with 24-hour and historical pricing before you buy.
-
How to buy Preferred Bank stock | 35.45
Steps to owning and managing PFBC, with 24-hour and historical pricing before you buy.
-
How to buy Canadian Solar stock | 40.37
Steps to owning and managing CSIQ, with 24-hour and historical pricing before you buy.
Ask an Expert